
    
      This was a single-center, randomized, open label, two-way cross over study conducted under
      non-fasting conditions. Subjects checked into the clinical facility the day prior to dosing
      at least 10 hours prior to dose administration. On study day 1, subjects were dosed with
      single oral dose (1x10mg tablet) of the test and reference products thirty minutes after
      initiation of a standardized, high fat breakfast which was preceded by an overnight fast.
      Following a seven day wash out period, subjects returned and were dosed with an alternative
      treatment as per randomization Thirty-six (N=36) volunteers were enrolled in the study of
      which 17 were females and 19 were males. Subject 22 was dropped from further study
      participation prior to period II check in due to adverse events
    
  